Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.
Level 5 - mechanism / opinion, no new human data
Expert consensus statement without primary clinical data
PubMed 35227529 · doi:10.1016/j.clnu.2021.11.014
What was done
An international expert panel appointed by ESPEN and EASO developed a consensus definition, diagnostic criteria, and staging framework for sarcopenic obesity.
What was found
The abstract reports no empirical data or quantitative metrics. The panel established a diagnostic algorithm requiring screening for elevated body mass index or waist circumference combined with markers or symptoms of skeletal muscle dysfunction, followed by functional muscle assessment and confirmatory body composition testing. Confirmed cases are stratified into Stage I (absence of complications) or Stage II (presence of complications linked to altered body composition or muscle dysfunction).
Why it matters
This consensus provides a unified diagnostic and staging framework to standardize research and clinical identification of individuals with co-existing obesity and sarcopenia.
Limits
The abstract describes an expert consensus statement with no primary human data, sample size, or diagnostic accuracy metrics reported. Operational thresholds and clinical predictive validity are not detailed in the abstract and remain to be tested.
Cited by
- supports Sarcopenic obesity is a medical phenotype where high levels of body fat co-occur with low skeletal muscle mass.